[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Yourgene Health Plc (YGEN) - Financial and Strategic SWOT Analysis Review

January 2020 | 52 pages | ID: Y045739CF31EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Yourgene Health Plc (YGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Yourgene Health Plc (Yourgene Health), formerly Premaitha Health Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that assists in estimating the risk of trisomy. The IONA test helps obviate the expensive, unnecessary and invasive diagnostic procedures such as amniocentesis. The company provides NIPT tests and services to clinical laboratories and healthcare professionals. The company offers its products directly to customers in Europe. It operates through a subsidiary, Yourgene Bioscience, in Taiwan, which provides it expanded market access in Asia. Yourgene Health is headquartered in Manchester, England, the UK.

Yourgene Health Plc Key Recent Developments

Dec 02,2019: Yourgene Health: Half-year Report
Nov 28,2019: Yourgene Health: Opening of new facilities and corporate HQ
Oct 14,2019: Yourgene Health: Half year trading update
Sep 26,2019: Yourgene Health: CE-IVD Certification renewal
Aug 19,2019: Yourgene Health: Change of Registered Office

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Yourgene Health Plc - Key Facts
Yourgene Health Plc - Key Employees
Yourgene Health Plc - Key Employee Biographies
Yourgene Health Plc - Key Operational Employees
Yourgene Health Plc - Major Products and Services
Yourgene Health Plc - History
Yourgene Health Plc - Company Statement
Yourgene Health Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Yourgene Health Plc - Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: UK
Performance
Yourgene Health Plc - Corporate Strategy
Yourgene Health Plc - SWOT Analysis
SWOT Analysis - Overview
Yourgene Health Plc - Strengths
Yourgene Health Plc - Weaknesses
Yourgene Health Plc - Opportunities
Yourgene Health Plc - Threats
Yourgene Health Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Yourgene Health Plc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Yourgene Health Plc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Yourgene Health Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Dec 02, 2019: Yourgene Health: Half-year Report
Nov 28, 2019: Yourgene Health: Opening of new facilities and corporate HQ
Oct 14, 2019: Yourgene Health: Half year trading update
Sep 26, 2019: Yourgene Health: CE-IVD Certification renewal
Aug 19, 2019: Yourgene Health: Change of Registered Office
Aug 16, 2019: Yourgene Health: Appointment of business development sector specialist as Non-executive Director
Jul 29, 2019: Yourgene Health appoints John Brown as non-executive director
Jul 10, 2019: Yourgene Health: Results for the year ended 31 March 2019, business update and director change

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Yourgene Health Plc, Key Facts
Yourgene Health Plc, Key Employees
Yourgene Health Plc, Key Employee Biographies
Yourgene Health Plc, Key Operational Employees
Yourgene Health Plc, Major Products and Services
Yourgene Health Plc, History
Yourgene Health Plc, Subsidiaries
Yourgene Health Plc, Key Competitors
Yourgene Health Plc, Ratios based on current share price
Yourgene Health Plc, Annual Ratios
Yourgene Health Plc, Annual Ratios (Cont...1)
Yourgene Health Plc, Interim Ratios
Yourgene Health Plc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Yourgene Health Plc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Yourgene Health Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Yourgene Health Plc, Performance Chart (2015 - 2019)
Yourgene Health Plc, Ratio Charts
Yourgene Health Plc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Yourgene Health Plc, Medical Equipment, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

OptiGene Ltd
GeneDX Inc
ERBA Molecular Ltd
Binx Health Inc
ANGLE Plc


More Publications